Research Projects

HEPATOX-AAV

Dr. Carmen Unzu Curriculum

Researcher Gene Therapy for Hereditary Hearing Loss and AAV Engineering Research Group

Research Division

DNA and RNA Medicine Division

Research group

Gene Therapy for Hereditary Hearing Loss and AAV Engineering. Research Group. Cima

Project information

The "HEPATOX-AAV" project is carried out in the DNA and RNA Therapies division, within the Rare Diseases Targeted Therapy program, under the direction of Carmen Unzu.

Funder: Pfizer

Start date: January 1, 2022
End date: December 31, 2024
Funder: Pfizer Inc.
Nature of project: Regional

Need more information?

If you are interested in learning more about our research, please contact us.